A Topamax, Topiramate CEP of the European Pharmacopoeia monograph is often referred to as a Topamax, Topiramate Certificate of Suitability (COS). The purpose of a Topamax, Topiramate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Topamax, Topiramate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Topamax, Topiramate to their clients by showing that a Topamax, Topiramate CEP has been issued for it. The manufacturer submits a Topamax, Topiramate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Topamax, Topiramate CEP holder for the record. Additionally, the data presented in the Topamax, Topiramate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Topamax, Topiramate DMF.
A Topamax, Topiramate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Topamax, Topiramate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Topamax, Topiramate suppliers with CEP (COS) on PharmaCompass.